ARTICLE | Clinical News
TPM/Oxymorphone patch: Phase I data
April 15, 2013 7:00 AM UTC
An Australian Phase I trial showed that a single patch application of Phosphagenics' TPM/oxymorphone patch "successfully" delivered oxymorphone into the bloodstream for the 72-hour duration of the stu...